SafeShield Antimicrobial Medical Waste Containers by Stericycle

Company to streamline medical waste collection with new portfolio of innovative containers to better serve customers and help protect communities

SafeShield antimicrobial medical waste containers, a line of high-quality, standardized containers, is specifically designed for the storage and transport of regulated medical waste (RMW).

Compared to Stericycle’s current containers, this new line of containers provides customers with an improved design, better storage options and an additional level of protection to help combat the growth of microorganisms on RMW containers. Stericycle previously began rolling out the containers to select U.S. markets and has planned a phased national rollout.

“Our SafeShield™ medical waste containers are designed to meet our customers’ needs as RMW generators,” commented Cory White, chief commercial officer at Stericycle. “The safe and efficient management of RMW helps hospitals and healthcare systems run more effectively. Through continued innovation and investment, Stericycle aims to provide safe, responsible and sustainable products and services that help healthcare organizations protect the health and well-being of the people and communities they serve, so they can focus on what matters most– patients.”

The new SafeShield™ containers include features such as:

  • Antimicrobial Properties: SafeShield™ containers are exclusively equipped with Cupron®, a copper-based antimicrobial additive to help prevent the growth of bacteria, fungi, mold and mildew, which can reduce odors and increase cleanliness. The containers also have a smooth interior finish with built-in drainage ports for easy cleaning.
  • Improved Design: These new, reusable RMW containers have an integrated lid that closes securely and eliminates lid misplacement. These containers are also nestable and stackable, enabling Stericycle drivers to load and transport more containers at one time.
  • Durability: SafeShield™ containers have reinforced handles to help withstand heavy loads. The split lid also securely locks and includes a tie area for added security during storage and transport.

Over the next several years, Stericycle will simplify its container portfolio and work with customers to transition from their current containers to the new models, ultimately aiming to reduce its line of more than 150 containers to less than 20. In 2021, approximately 75,000 new SafeShield™ containers were delivered to customers. In 2022, Stericycle plans to ship approximately 290,000 SafeShield™ containers to customers across the U.S. with an additional phased roll-out to follow. As the new containers are introduced in the marketplace, Stericycle will recycle as many of the decommissioned containers as possible to help reduce landfill waste.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.